International trends in pulmonary neuroendocrine cancer studies:a scientometric study

ABSTRACT

Introduction

Pulmonary neuroendocrine tumors account for approximately 20% of all primary lung tumors. Few studies summarize the current body of pulmonary neuroendocrine tumors studies worldwide.

Objective

A quantitative scientometric analysis was conducted to evaluate the development of applications and innovations and to analyze their contribution to various areas of improvement in treatment and diagnosis of pulmonary neuroendocrine tumors.

Methods

We searched for studies published in the last 20 years in the databases United States National Library of Medicine (PubMed), Scientific Electronic Library Online (SciELO), Scopus, and Web of Science, using the terms ‘pulmonary neuroendocrine tumors’, ‘bronchial neuroendocrine tumors’, ‘bronchial carcinoid tumors’, ‘pulmonary carcinoid’, ‘typical pulmonary carcinoid’, ‘atypical pulmonary carcinoid’, ‘pulmonary carcinoid and diagnosis’, ‘pulmonary carcinoid and treatment’, ‘pulmonary carcinoid and epidemiology’ and ‘pulmonary carcinoid and prognosis’.

Results

Our results showed the number of publications increased significantly over the study period and was strongly associated with the economic or financial situation of the publications’ countries of origin. We observed a predominance of studies on histological diagnosis compared to treatment, and among the studies related to treatment, a predominance of retrospective studies relative to prospective studies was found.

Conclusion

Based on the published literature, we concluded research on pulmonary neuroendocrine tumors still seems to be incipient, because it favors studies related to histological characterization of the disease, and therapeutic studies are still predominantly of a retrospective nature.

Scienciometry; Scientometric analysis; Lung neoplasms; Neuroendocrine tumors